AI assistant
Beta Bionics, Inc. — Director's Dealing 2025
Jan 30, 2025
32351_dirs_2025-01-29_baa22f4d-dc9e-43d6-96e2-62c6c91124a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-01-29
Reporting Person: Jones Christy (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Director Stock Option (right to buy) | $7.51 | 2031-12-07 | Class B Common Stock (9137) | Direct | |
| Director Stock Option (right to buy) | $7.51 | 2031-12-07 | Class B Common Stock (9137) | Direct | |
| Directo Stock Option (right to buy) | $7.51 | 2032-07-26 | Class B Common Stock (48730) | Direct |
Footnotes
F1: The shares subject to this option shall vest in 36 equal monthly installments measured from April 27, 2021.
F2: In accordance with the Issuer's Amended and Restated Certificate of Incorporation, the Issuer's outstanding shares of Class B Common Stock will convert into an equal number of shares of Common Stock immediately prior to the closing of the initial public offering.
F3: The shares subject to this option shall vest in 36 equal monthly installments measured from July 20, 2021.
F4: The shares subject to this option shall vest in 48 equal monthly installments measured from July 27, 2022.